Summary & Overview
CPT 86663: EBV Early Antigen (EA) Antibody Immunoassay
CPT code 86663 represents a laboratory immunoassay that detects antibodies to the early antigen (EA) of Epstein–Barr virus (EBV) in serum, a marker often associated with acute or recent EBV infection. This code is clinically important nationally because EBV is a common viral infection with implications for diagnosis of infectious mononucleosis and related complications; accurate serologic testing informs clinical management and public health surveillance. Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose of the test, typical site-of-service context, and what to expect in a benchmarking and policy-oriented review. The publication covers reimbursement benchmarks, common billing and coding considerations, payer coverage patterns, and relevant clinical context for interpreting 86663. Where data is unavailable in the input, the report notes missing fields rather than inferring specifics. This material is written for a national audience and focuses on practical information about the code’s role in laboratory diagnostics, payer coverage considerations, and areas where policy updates or payer guidelines commonly affect billing and utilization.
Billing Code Overview
CPT code 86663 describes an immunoassay performed by a laboratory analyst to detect antibodies to the early antigen (EA) of Epstein–Barr virus (EBV) in a patient’s serum. This test is used to evaluate humoral immune response consistent with acute or recent EBV infection and can assist clinical diagnosis when correlated with patient symptoms and other laboratory results.
-
Service type: Laboratory diagnostic immunoassay
-
Typical site of service: Clinical laboratory or hospital laboratory processing serum samples
Data not available in the input for payers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 19-year-old college student presents to an outpatient clinic with 2 weeks of fever, sore throat, generalized fatigue, and posterior cervical lymphadenopathy. The primary clinician suspects infectious mononucleosis and orders serologic testing for Epstein–Barr virus (EBV). A serum sample is collected via venipuncture and sent to the clinical laboratory. The laboratory performs an immunoassay to detect IgM and/or IgG antibodies directed against the EBV early antigen (EA) using CPT 86663. Results reporting includes the quantitative or qualitative EA antibody result, interpretation (consistent with acute, recent, or past infection), and a technician or lab analyst signature when required.
Typical site of service: outpatient phlebotomy/ambulatory clinic or independent laboratory (clinical laboratory testing). Typical clinical workflow: clinician orders EBV serology → specimen collection and labeling → specimen transported to the laboratory → laboratory accessioning and performing immunoassay (CPT 86663) → result validation and reporting to ordering provider; reflex testing (e.g., heterophile antibody test, EBV viral capsid antigen IgM/IgG, EBV nuclear antigen IgG) may follow based on results.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default / No modifier | Use when no other modifier applies and standard billing is appropriate |
26 | Professional component | Use when billing only the professional interpretation component for laboratory testing when separated from technical component |
TC | Technical component | Use when billing only the technical component (laboratory performance of the assay) |
90 | Reference (outside) laboratory | Use when the test was performed by an outside reference laboratory and billed by the ordering laboratory |
91 | Repeat clinical diagnostic laboratory test | Use when a repeat test is performed on the same day for validation or monitoring |
52 | Reduced services | Use when the test was partially reduced or not performed as originally intended |
53 | Discontinued procedure | Use when specimen collection or testing was started but discontinued for medical reasons |
59 | Distinct procedural service | Use when this lab test is a distinct service from another billed procedure on the same day |
95 | Synchronous telemedicine service – skilled non-physician | Use when remote interpretation or consultation for the laboratory result is provided synchronously and payer allows |
91 | Repeat clinical diagnostic laboratory test | See above; used for repeated analyses (included to emphasize common use) |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207Q00000X | Clinical Pathology | Laboratory directors and pathologists overseeing immunoassay testing |
| 207LP2900X | Medical Laboratory Technologist | Performs and validates the assay in the clinical laboratory |
| 208D00000X | Diagnostic Laboratory | Organizations/individuals responsible for performing clinical diagnostic tests |
| 207L00000X | Clinical Laboratory | General clinical laboratory specialty involved in performing CPT 86663 |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
B27.90 | Infectious mononucleosis, unspecified | Primary diagnosis prompting EBV EA antibody testing to evaluate acute EBV infection |
B27.89 | Other infectious mononucleosis | Used when specifying other forms of mononucleosis; EBV serology helps confirm etiology |
R50.9 | Fever, unspecified | Non-specific presenting symptom that may trigger evaluation including EBV serology |
J02.9 | Acute pharyngitis, unspecified | Sore throat differential includes EBV; EA antibody testing helps distinguish viral causes |
R53.83 | Other fatigue | Persistent fatigue evaluation may include EBV serology when infectious causes are suspected |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
86762 | Heterophile antibodies (Monospot) | Common initial point-of-care or laboratory screen for infectious mononucleosis; may be ordered before or alongside CPT 86663 |
86664 | EBV viral capsid antigen (VCA) IgM and IgG immunoassay | Complementary EBV serology used with EA antibody testing to distinguish acute versus past infection |
86789 | Viral antibody, not otherwise classified (e.g., EBV nuclear antigen IgG) | Used for additional EBV-specific antibody testing such as EBV nuclear antigen to assess past infection |
36415 | Collection of venous blood by venipuncture | Specimen collection CPT commonly performed prior to laboratory testing like CPT 86663 |
80053 | Comprehensive metabolic panel | Frequently ordered concurrently to evaluate general health and organ function during acute illness |